Patent 7256208 was granted and assigned to Bristol-Myers Squibb on August, 2007 by the United States Patent and Trademark Office.
The present invention relates to novel compounds useful in the treatment of androgen receptor associated conditions, such as age-related diseases, pharmaceutical compositions containing at least one of the compounds of the present invention and methods of treating a patient in need of therapy for an androgen receptor associated condition by administering a therapeutically effective amount of at least compound of the present invention.